|Podcasts|April 1, 2022
Advancing Pharmacovigilance
Author(s)Nicholas Saraceno, Senior Editor, Julian Upton
A look into the current state of the market, along with developments in the space
Advertisement
Glenn Carroll, safety leader and principal at Deloitte Consulting, a firm that has collaborated with a Big Pharma company on an AI software-as-a-service platform, details the obstacles that drug safety providers face today, and how the competitive landscape is evolving as new entrants join the field.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
BoomRx Expands Access to Oral Semaglutide and Tirzepatide Using Nanoemulsion Delivery
2
The Hidden Economics of Health Insurance Affordability
3
Pharma Pulse: Novartis Warns of Trade Fragmentation; Hospital M&A Hits Record Low; Copay Shock Warning
4
Evaluate’s 2026 Pharma Forecast Signals Cautious Recovery, Rising M&A, and GLP-1 Market Shifts
5